Letter to the shareholders
We would like to use this opportunity to inform you that we have now started the human clinical safety trial in UK and the first patients are now enrolled. Read more
We would like to use this opportunity to inform you that we have now started the human clinical safety trial in UK and the first patients are now enrolled. Read more